Pasithea Therapeutics Corp. — Director's Dealing 2021

Oct 7, 2021

SEC Form 3/A — Form 3/A

Issuer: Pasithea Therapeutics Corp. (KTTA)
CIK: 0001841330
Period of Report: 2021-09-14

Reporting Person: Abramowitz Israel Maxx (Not a 10% owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1051575	Indirect

Footnotes

F1: This Form 3 was originally and incorrectly filed to disclose Israel Maxx Abramowitz as a 10% holder, specifically owning 1,051,575 shares of Common Stock through Epic Capital Inc. ("Epic"). At the time this Form 3 was originally filed, Mr. Abramowitz was the President and CEO of Epic and had sole voting and investment control with respect to the shares held by Epic. As such, Mr. Abramowitz may have be deemed to beneficially own the shares held directly by Epic. At this time, the 1,051,575 shares of Common Stock held by Epic represent less than 10% of the Common Stock. This amended Form 3/A discloses that Mr. Abramowitz is not a 10% holder.